Fumie Griego is a member of the 2022 Expert Review Committee for the Access to Medicine Index. She was also a member of the ERC in 2018.
Fumie is Deputy Director General and Chief Operating Officer at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), where she leads the organisation’s strategic planning and work on health economics and policy such as on the value of medicines, pricing and reimbursement, and metrics/evaluation. Prior to joining the IFPMA, Fumie was Head of Global Oncology Policy and Strategy, Global Government Affairs & Policy at Merck KGaA and Vice President for International Health Policy at Pharmaceutical Research and Manufacturers of America (PhRMA). Fumie was also a senior economist in the White House’s Office of Management and Budget where she provided U.S. senior officials in both the Bush and Obama Administrations with policy advice on a range of health policy issues.